Penjualan Perubahan Tanggal
Abbott USD 13.01B 423M 2026-09
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 24.4B 1.43B 2026-09
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Illumina USD 1.17B 10M 2026-09
Insmed USD 524.42M 98.93M 2026-09
Ironwood Pharmaceuticals USD 113.04M 6.53M 2026-06
J&J USD 25.4B 89M 2026-09
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
MacroGenics USD 32.83M 12.03M 2026-06
MannKind USD 101.9M 7.47M 2026-09
Merck USD 18.1B 1.5B 2026-09
Moderna USD 1.31M 98.69M 2026-09
Novartis USD 14.52B 112M 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Thermo Fisher Scientific USD 12.14B 147M 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
United Therapeutics USD 832.5M 49.2M 2026-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12